A Molecular Staging Study of Endometrial Carcinoma
Principal Investigator
,
Status
Terminated
Date of Study Termination
January 11 2021
Disease Site
Gynecologic [GY]
Uterine Corpus
Phase
I
Developmental Therapeutics
No
Primary Objective
Patient Population
Target Accrual
Patient Study Webpage
There is no available patient study webpage available for this trial at this time.